about
Outcomes after stereotactic body radiotherapy for lung tumors, with emphasis on comparison of primary lung cancer and metastatic lung tumors.Long-term results of radiotherapy combined with nedaplatin and 5-fluorouracil for postoperative loco-regional recurrent esophageal cancer: update on a phase II study.Impact of tumor attachment to the pleura measured by a pretreatment CT image on outcome of stage I NSCLC treated with stereotactic body radiotherapy.Assessment of myocardial metabolic disorder associated with mediastinal radiotherapy for esophageal cancer -a pilot study.Long-term results of chemoradiotherapy for stage II-III thoracic esophageal cancer in a single institution after 2000 -with a focus on comparison of three protocolsTreatment outcome of high-dose image-guided intensity-modulated radiotherapy using intra-prostate fiducial markers for localized prostate cancer at a single institute in Japan.Renal atrophy after stereotactic body radiotherapy for renal cell carcinoma.Lung stereotactic radiotherapy for oligometastases: comparison of oligo-recurrence and sync-oligometastases.Metabolic tumor volume on FDG-PET/CT is a possible prognostic factor for Stage I lung cancer patients treated with stereotactic body radiation therapy: a retrospective clinical study.Chemoradiotherapy for T4 and/or M1 lymph node esophageal cancer: experience since 2000 at a high-volume center in Japan.Evaluation of rectum and bladder dose accumulation from external beam radiotherapy and brachytherapy for cervical cancer using two different deformable image registration techniques.Dose Escalation Improves Outcome in Stereotactic Body Radiotherapy for Pulmonary Oligometastases from Colorectal Cancer.Evaluation of deformable image registration between external beam radiotherapy and HDR brachytherapy for cervical cancer with a 3D-printed deformable pelvis phantom.Definitive Chemoradiotherapy for Advanced Pulmonary Sarcomatoid CarcinomaComparison of visual biofeedback system with a guiding waveform and abdomen-chest motion self-control system for respiratory motion management.Elective nodal irradiation is not necessary in chemoradiotherapy for postoperative loco-regional recurrent esophageal cancer.Evaluation of the performance of deformable image registration between planning CT and CBCT images for the pelvic region: comparison between hybrid and intensity-based DIR.Dosimetric evaluation of MLC-based dynamic tumor tracking radiotherapy using digital phantom: Desired setup margin for tracking radiotherapy.Clinical utility of texture analysis of 18F-FDG PET/CT in patients with Stage I lung cancer treated with stereotactic body radiotherapy.Impact of a commercially available model-based dose calculation algorithm on treatment planning of high-dose-rate brachytherapy in patients with cervical cancer.Prognostic Value of Radiation Pneumonitis After Stereotactic Body Radiotherapy: Effect of Pulmonary Emphysema Quantitated Using CT Images.Formula corrected maximal standardized uptake value in FDG-PET for partial volume effect and motion artifact is not a prognostic factor in stage I non-small cell lung cancer treated with stereotactic body radiotherapy.Whole-body total lesion glycolysis is an independent predictor in patients with esophageal cancer treated with definitive chemoradiotherapy.Dosimetric impact of 4-dimensional computed tomography ventilation imaging-based functional treatment planning for stereotactic body radiation therapy with 3-dimensional conformal radiation therapy.Assessment and agreement of the CT appearance pattern and its severity grading of radiation-induced lung injury after stereotactic body radiotherapy for lung cancerStereotactic Radiotherapy for Pulmonary Oligometastases From Colorectal Cancer: A Systematic Review and Meta-AnalysisEvaluation of functionally weighted dose-volume parameters for thoracic stereotactic ablative radiotherapy (SABR) using CT ventilationImpact of change in serum albumin level during and after chemoradiotherapy in patients with locally advanced esophageal cancerOesophageal squamous cell carcinoma: histogram-derived ADC parameters are not predictive of tumour response to chemoradiotherapyEvaluation of four-dimensional computed tomography (4D-CT)-based pulmonary ventilation: The high correlation between 4D-CT ventilation and 81mKr-planar images was found
P50
Q33826696-52EB106D-E206-4309-B0FE-88AC4FB71B3BQ34484367-5BA64F1A-1119-4457-B8BD-BCB590AA5CFCQ35074232-F00DF050-EE61-4BC5-951D-968BE11715A1Q35530285-ECDFFCF7-5DD8-4683-99C4-3F701680B01AQ35823373-0BC75F03-7402-4D71-A85C-BA5C4B801117Q36384072-8928FE29-D464-499C-9D3B-892CAD9B8135Q36938199-88FFDA5F-7916-4DBE-AC0A-815D2572AEADQ37117211-C5549B84-3BF9-449A-884E-D7FA3DBA7F0BQ37472654-43231679-7C7E-4AE2-978A-9AC8053A7549Q38577792-524C4720-408C-4223-8AE8-9930FD24C237Q38736073-7BA11707-A5CC-4AD1-AF0B-0B3F32EE429CQ38801355-AE900A7E-4EC5-4757-A1C9-3E2184F198CEQ38954079-B90C7FEA-B9BB-4F8E-A215-6E2A42FEE7DCQ39555967-328A608A-98AF-48D7-A960-81B07339381BQ39963548-F1D6A38B-396A-4D3F-9DA7-7548B351B5DFQ40403996-27D4D396-7B72-4864-853C-F358AF058235Q41510158-702A5DA2-31AE-4042-8C4E-53BFEBA52E55Q41993340-481D4720-C2CB-4FA2-B637-A1518B93CB4DQ47227265-C4F26B26-7875-448E-B115-96395073E752Q47555328-16A28768-03B9-477A-BBAB-761B2A8D4FA7Q47717142-D0F81817-B325-4322-BF8C-6D6559AB0007Q48794414-EB997EB0-FEAE-4BAB-964A-1DEF501E14AAQ50133780-4F1A8338-D3A5-4DF3-95E0-8BE88DFA536BQ51580264-93CE9D05-605E-4A01-83A3-FAC3CEEC9D3FQ57031323-0B61D9E0-C617-4E40-9ED0-C9E62DD16A64Q57768371-8FA873B4-D136-40E7-A432-E92296AE1D40Q57768375-FFB482CF-0433-4F96-862C-BC443AF00704Q57768378-1AF37EAE-E58F-4B24-A90C-324F6B894705Q57768380-46891B83-672E-4430-AD3D-40AD9803CB6BQ57768386-3CFC5CA8-5C05-4575-A858-19BEB7E91883
P50
description
researcher ORCID ID = 0000-0003-3562-1037
@en
wetenschapper
@nl
name
Takaya Yamamoto
@ast
Takaya Yamamoto
@en
Takaya Yamamoto
@es
Takaya Yamamoto
@nl
type
label
Takaya Yamamoto
@ast
Takaya Yamamoto
@en
Takaya Yamamoto
@es
Takaya Yamamoto
@nl
prefLabel
Takaya Yamamoto
@ast
Takaya Yamamoto
@en
Takaya Yamamoto
@es
Takaya Yamamoto
@nl
P106
P1153
55292774000
P31
P496
0000-0003-3562-1037